Biopharmaceutical

Summary

Table of Contents

Data Series

  • Publication date: August 2012
  • Report size: 46 pages
Keywords : biosimilar, interferon beta, Monoclonal Antibody, Biopharmaceutical, Erythropoietin, Infliximab, Abciximab, ReliPoietin

This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development such as clinical trials (where available) for each key biosimilar molecule in development....

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Alison

00 1 718 618 48 97

Send Your Request

Share

Biopharmaceutical Industry in India : Latest Reports

Analytical Tool - Antibodies and Peptides in Oncology

Analytical Tool - Antibodies and Peptides in Oncology

  • $ 8 925
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

  • $ 4 650
  • Industry report
  • March 2013
  • by MarketsandMarkets

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...

Food Enzymes Market By Types (Carbohydrase, Protease, Lipase), Applications (Beverages, Dairy, Bakery), Sources (Microorganisms, Plants, Animals) & Geography - Global Trends & Forecasts To 2018

Food Enzymes Market By Types (Carbohydrase, Protease, Lipase), Applications (Beverages, Dairy, Bakery), Sources (Microorganisms, Plants, Animals) & Geography - Global Trends & Forecasts To 2018

  • $ 4 650
  • Industry report
  • June 2013
  • by MarketsandMarkets

Food enzymes act as highly selective catalyst and function in the metabolic reactions and in the inter conversion of complex molecules to smaller ones. Enzymes form an integral part of the global food ...


Biopharmaceutical Industry in India : Latest Downloads

Enzyme Sector Analysis

Enzyme Sector Analysis

  • Industry report
  • March 2013
  • 90 pages

... Production Preparation of enzymes 21/03/2013 why enzymes Catalysts increase the rate of reactions without any net change in their structure. Concept of catalysis is developed as early as the 19th ...

Biopharmaceutical Industry Brief

Biopharmaceutical Industry Brief

  • Industry report
  • October 2012
  • 8 pages

... Alfa was non-inferior to imiglucerase if the lower limit of the one-sided 97.5% Confidence interval (ci) of the treatment difference (velaglucerase alfa minus imiglucerase) was greater than -1 g ...

Biopharmaceutical Sector Brief

Biopharmaceutical Sector Brief

  • Industry report
  • October 2012
  • 6 pages

... E in upstream and downstream development. As an example of pharmaceutical proteins whole production processes of potential malaria vaccines are investigated in detail. In the field of technical enzymes ...

Antibody Market Brief

9 months ago

Biosimilar Sector Brief

10 months ago

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.